Sera Prognostics, Inc. (SERA)
2.09
+0.05
(+2.45%)
USD |
NASDAQ |
Oct 02, 16:00
2.11
+0.02
(+0.96%)
After-Hours: 20:00
Sera Prognostics EPS Diluted (Quarterly) : -0.181 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.181 |
| March 31, 2026 | -0.1671 |
| December 31, 2025 | -0.1577 |
| September 30, 2025 | -0.1578 |
| June 30, 2025 | -0.164 |
| March 31, 2025 | -0.1951 |
| December 31, 2024 | -0.2528 |
| September 30, 2024 | -0.2362 |
| June 30, 2024 | -0.2521 |
| March 31, 2024 | -0.2513 |
| December 31, 2023 | -0.2523 |
| September 30, 2023 | -0.2304 |
| June 30, 2023 | -0.3392 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.3406 |
| December 31, 2022 | -0.3142 |
| September 30, 2022 | -0.3455 |
| June 30, 2022 | -0.3723 |
| March 31, 2022 | -0.3963 |
| December 31, 2021 | -0.4057 |
| September 30, 2021 | -0.3212 |
| June 30, 2021 | -0.2054 |
| March 31, 2021 | -0.2071 |
| December 31, 2020 | -0.1751 |
| September 30, 2020 | -0.1652 |
| June 30, 2020 | -0.1533 |
| March 31, 2020 | -0.153 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -0.4557 |
| BioRestorative Therapies, Inc. | -2.431 |
| CareDx, Inc. | 2.071 |
| Natera, Inc. | -0.4674 |
| Exagen, Inc. | -0.1323 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.139M |
| Revenue (Quarterly) | 0.03M |
| Total Expenses (Quarterly) | 9.169M |
| Enterprise Value | 38.98M |
| Gross Profit Margin (Quarterly) | -606.7% |
| Profit Margin (Quarterly) | -30.46K% |
| Earnings Yield | -31.75% |
| Normalized Earnings Yield | -31.75 |